AAAAAA

   
Results: 1-9 |
Results: 9
DEVELOPMENT OF MONOCLONAL-ANTIBODIES SPECIFIC FOR HUMAN GLANDULAR KALLIKREIN (HK2) - DEVELOPMENT OF A DUAL ANTIBODY IMMUNOASSAY FOR HK2 WITH NEGLIGIBLE PROSTATE-SPECIFIC ANTIGEN CROSS-REACTIVITY
Authors: FINLAY JA EVANS CL DAY JR PAYNE JK MIKOLAJCZYK SD MILLAR LS KUUSREICHEL K WOLFERT RL RITTENHOUSE HG
Citation: Ja. Finlay et al., DEVELOPMENT OF MONOCLONAL-ANTIBODIES SPECIFIC FOR HUMAN GLANDULAR KALLIKREIN (HK2) - DEVELOPMENT OF A DUAL ANTIBODY IMMUNOASSAY FOR HK2 WITH NEGLIGIBLE PROSTATE-SPECIFIC ANTIGEN CROSS-REACTIVITY, Urology, 51(5), 1998, pp. 804-809
COMPARISON OF TECHNETIUM-99M-HMPAO AND XE-133 MEASUREMENTS OF REGIONAL CEREBRAL BLOOD-FLOW BY SPECT
Authors: PAYNE JK TRIVEDI MH DEVOUS MD
Citation: Jk. Payne et al., COMPARISON OF TECHNETIUM-99M-HMPAO AND XE-133 MEASUREMENTS OF REGIONAL CEREBRAL BLOOD-FLOW BY SPECT, The Journal of nuclear medicine, 37(10), 1996, pp. 1735-1740
SITE-SPECIFIC PRODRUG ACTIVATION BY ANTIBODY-BETA-LACTAMASE CONJUGATES - PRECLINICAL INVESTIGATION OF THE EFFICACY AND TOXICITY OF DOXORUBICIN DELIVERED BY ANTIBODY-DIRECTED CATALYSIS
Authors: MEYER DL LAW KL PAYNE JK MIKOLAJCZYK SD ZARRINMAYEH H JUNGHEIM LN KING JK SHEPHERD TA STARLING JJ
Citation: Dl. Meyer et al., SITE-SPECIFIC PRODRUG ACTIVATION BY ANTIBODY-BETA-LACTAMASE CONJUGATES - PRECLINICAL INVESTIGATION OF THE EFFICACY AND TOXICITY OF DOXORUBICIN DELIVERED BY ANTIBODY-DIRECTED CATALYSIS, Bioconjugate chemistry, 6(4), 1995, pp. 440-446
A 2-STEP DELIVERY SYSTEM UTILIZING A BI-SPECIFIC MONOCLONAL-ANTIBODY FOR RADIOIMMUNOTHERAPY
Authors: SANTOS O PAYNE JK DOMITROWSKY JB BERKELEY C MACKENSEN DG
Citation: O. Santos et al., A 2-STEP DELIVERY SYSTEM UTILIZING A BI-SPECIFIC MONOCLONAL-ANTIBODY FOR RADIOIMMUNOTHERAPY, Antibody immunoconjugates, and radiopharmaceuticals, 8(2), 1995, pp. 93-109
CHANGES IN RESTING RCBF ABNORMALITIES IN MAJOR DEPRESSION AFTER TREATMENT WITH FLUOXETINE
Authors: TRIVEDI MH DEVOUS MD GONG W PAYNE JK RUSH AJ
Citation: Mh. Trivedi et al., CHANGES IN RESTING RCBF ABNORMALITIES IN MAJOR DEPRESSION AFTER TREATMENT WITH FLUOXETINE, The Journal of nuclear medicine, 35(5), 1994, pp. 160000054-160000054
CLINICAL-EVALUATION OF TC-99M HMPAO RELATIVE TO XE-133 FOR REGIONAL CEREBRAL BLOOD-FLOW SPECT IMAGING
Authors: PAYNE JK TRIVEDI MH HARRIS TS DEVOUS MD
Citation: Jk. Payne et al., CLINICAL-EVALUATION OF TC-99M HMPAO RELATIVE TO XE-133 FOR REGIONAL CEREBRAL BLOOD-FLOW SPECT IMAGING, The Journal of nuclear medicine, 35(5), 1994, pp. 160000212-160000212
DYNAMIC QUANTITATIVE XE-133 RCBF SPECT ON THE PRISM 3-HEADED TOMOGRAPHY - HUMAN STUDIES
Authors: DEVOUS MD GONG W PAYNE JK HARRIS TS
Citation: Md. Devous et al., DYNAMIC QUANTITATIVE XE-133 RCBF SPECT ON THE PRISM 3-HEADED TOMOGRAPHY - HUMAN STUDIES, The Journal of nuclear medicine, 34(5), 1993, pp. 68-68
DYNAMIC QUANTITATIVE XE-133 RCBF SPECT ON THE PRISM 3-HEADED TOMOGRAPH - SIMULATION AND PHANTOM STUDIES
Authors: DEVOUS MD GONG W PAYNE JK
Citation: Md. Devous et al., DYNAMIC QUANTITATIVE XE-133 RCBF SPECT ON THE PRISM 3-HEADED TOMOGRAPH - SIMULATION AND PHANTOM STUDIES, The Journal of nuclear medicine, 34(5), 1993, pp. 91-91
COMPARISON OF TECHNETIUM-99M-ECD TO XE-133 SPECT IN NORMAL CONTROLS AND IN PATIENTS WITH MILD-TO-MODERATE REGIONAL CEREBRAL BLOOD-FLOW ABNORMALITIES
Authors: DEVOUS MD PAYNE JK LOWE JL LEROY RF
Citation: Md. Devous et al., COMPARISON OF TECHNETIUM-99M-ECD TO XE-133 SPECT IN NORMAL CONTROLS AND IN PATIENTS WITH MILD-TO-MODERATE REGIONAL CEREBRAL BLOOD-FLOW ABNORMALITIES, The Journal of nuclear medicine, 34(5), 1993, pp. 754-761
Risultati: 1-9 |